PSYC Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights
- Wall Street closes rollercoaster week sharply lower
- Invesco (IVZ) Reportedly in Talks to Merge With State Street's (STT) Asset Management Business, Citi Sees More Cons than Pros
- FDA Votes "No" on Pfizer (PFE) Booster for 16+ Age Group, 2 Yes 16 No
- Jefferies Raises Price Targets on Alphabet (GOOGL) and Facebook (FB) as They Are Still Inexpensive Relative to Growth, Reiterates Snap (SNAP) as a Best Growth Idea
- Tesla (TSLA) Could Deliver 900K EV Units This Year and 1.3M in 2022 - Wedbush
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
LAS VEGAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that in an effort to accelerate the Company’s development of premium industry centric content for its Psychedelic Spotlight website (www.psychedelicspotlight.com) and Microdose Monthly newsletter, PSYC has established a content development partnership with Microdose Psychedelic Insights (“Microdose”) (www.microdose.buzz), the leader in psychedelic media and events based out of Toronto, Canada.
Through this partnership with Microdose, PSYC will have the distinct ability to work in a collaborative effort with Microdose’s talented and knowledgeable content development team to produce and present original, broad-minded content that offers a unique and in-touch perspective related to the emerging space of psychedelic medicine.
Said Global Trac Solutions, Inc. CEO David Flores: “We are delighted to have established this outstanding partnership with a firm like Microdose who have such a compelling and impressive finger on the pulse of the medicinal psychedelic industry. More importantly, I am thrilled to partner and work with a company where our passion, principles, and overall vision within this industry are so perfectly aligned and the opportunity it will present to unify each of these critical aspects in producing exceptional informational and educational-focused content that I hope will contribute to the advancement of psychedelic medicines as a recognized treatment. It is also our intent to leverage this terrific opportunity to more distinctly develop our identity and expand our reach within this quickly evolving sector.”
Said Patrick Moher, Microdose Partner: “We are pleased to be aligning the team at Psychedelic Spotlight, amplify our ability to produce high quality, evidence based, original psychedelic content. We believe that collaboration is critical to create a successful industry in the long term and are excited to see where this partnership takes us.”
In addition to this partnership, the Company has also demonstrated considerable focus in recent weeks towards expanding its pool of talented and experienced freelance writers within the field of medicinal psychedelics and with the intent of increasing its production and output of original content over the next several weeks and in the months ahead.
About Global Trac Solutions, Inc. (OTCPink: PSYC)
Global Trac Solutions is a diversified holding company dedicated to identifying new and emerging industries. By utilizing our years of business development expertise our diverse team of innovators continuously leverages our experience to effectively execute go-to-market strategies in order to position ourselves for rapid growth through the creation of an evolving business foundation to enhance profitability potential.
PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.
We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.
About Microdose Psychedelic Insights
Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry's most influential stakeholders, some of the world's best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.
Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
- United Nations Global Compact recognizes most engaged companies in 2021
- The Western China International Fair (WCIF) Holds in Chengdu on September 16-20, 2021
Create E-mail Alert Related CategoriesGlobe Newswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!